Skip to main content
. 2017 Oct 10;39(1):26–35. doi: 10.1093/eurheartj/ehx564

Figure 5.

Figure 5

Observed change in LVEF in survivors. Change in left ventricular ejection fraction (LVEF) from baseline in patients who survived to follow-up, with median time between measurements of 1.0 years (interquartile range 0.3–2.0 years). Those with follow-up LVEF were older in age compared to those without follow-up LVEF [67 (IQR 56–74) vs. 64 (55–71) years, respectively], but with similar baseline LVEF [27% (20–33) vs. 27% (21–33)] and frequency of ischaemic cardiomyopathy (65% vs. 67%). The variance for each category of change in LVEF (beta-blockers vs. placebo) is presented in Table 3. (A) Sinus rhythm; n = 4, 601 patients. (B) Atrial fibrillation; n = 996.